These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 11373776)
1. [Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor]. MMW Fortschr Med; 2001 Apr; 143 Suppl 1():39. PubMed ID: 11373776 [No Abstract] [Full Text] [Related]
2. Non-nucleoside reverse transcriptase inhibitors--an overview. Bell C; Matthews GV; Nelson MR Int J STD AIDS; 2003 Feb; 14(2):71-7. PubMed ID: 12662384 [No Abstract] [Full Text] [Related]
3. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection]. van Leth F; Lange JM Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943 [TBL] [Abstract][Full Text] [Related]
4. [Efavirenz--comprehensive status of studies]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():79-81. PubMed ID: 16385886 [No Abstract] [Full Text] [Related]
5. Factors affecting adherence and convenience in antiretroviral therapy. Lafeuillade A Int J STD AIDS; 2001 Nov; 12 Suppl 4():18-24. PubMed ID: 11589824 [No Abstract] [Full Text] [Related]
6. NNRTI hepatotoxicity: efavirenz versus nevirapine. Pulido F; Torralba M J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215 [No Abstract] [Full Text] [Related]
7. The tolerability of efavirenz after nevirapine-related adverse events. Clarke S; Harrington P; Barry M; Mulcahy F Clin Infect Dis; 2000 Sep; 31(3):806-7. PubMed ID: 11017835 [TBL] [Abstract][Full Text] [Related]
16. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary]. MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921 [No Abstract] [Full Text] [Related]